evaluating satraplatin

Related by string. * EVALUATING . Evaluated . EVALUATED . evaluated . Evaluating : evaluating CK # . rigorously evaluated . When evaluating Antigenics . Intervention Trial Evaluating . evaluating OGX . prospectively evaluated . evaluating Nexavar / Satraplatin : satraplatin Phase . marketed satraplatin . satraplatin * evaluating satraplatin plus . studies evaluating satraplatin *

Related by context. Frequent words. (Click for all words.) 75 refractory chronic lymphocytic 74 R sorafenib tablets 72 Initiates Phase II 70 forodesine 70 Gemzar ® 70 elotuzumab 70 deforolimus 69 Phase Ib II 69 TELINTRA 69 HGS ETR2 69 Initiate Phase 69 IMC #B 68 Ixempra 68 Nexavar ® 68 pertuzumab 68 Meets Primary Endpoint 68 INCB# [001] 68 liposomal formulation 67 metastatic castration resistant 67 Panzem R 67 PLK1 SNALP 67 sunitinib malate 67 Receives Orphan Drug Designation 67 Pivotal Phase III 66 phase IIb clinical 66 PEG SN# 66 ThermoDox R 66 multi kinase inhibitor 66 metastatic hormone refractory 66 ongoing Phase 1b 66 Pivotal Phase 66 AzaSite Plus 66 developing Zerenex TM 66 TLR9 agonists 65 enzastaurin 65 HCV protease inhibitor 65 ANYARA 65 docetaxel chemotherapy 65 SAR# [004] 65 Dapagliflozin 65 drug conjugate 65 Vytorin combines 65 Presents Positive 65 KRN# 65 confirmatory Phase III 65 squalamine 65 Tesetaxel 65 JAK inhibitor 65 HGS ETR1 65 registrational trial 65 proteasome inhibitor 65 Phase III Clinical Trial 65 Laquinimod 65 ixabepilone 65 Completes Enrollment 64 TOCOSOL Paclitaxel 64 NVA# 64 Irinotecan 64 inhaled formulation 64 Bicifadine 64 BCX# 64 Allovectin 7 ® 64 JAK1 64 Ustekinumab 64 custirsen 64 tanespimycin 64 ALN TTR# 64 MEK inhibitor 64 Copegus R 64 Kuvan R 64 Phase Ib clinical 64 Drug Candidate 64 subcutaneous formulation 64 ATL# [001] 64 NXL# 64 SARMs 64 Daclizumab 64 NEBIDO R 64 GVAX R 64 nucleoside reverse transcriptase inhibitor 64 MKC# 64 TRISENOX 64 FDA Accepts 64 EndoTAG TM -1 64 anticancer compound 64 SUCCEED trial 64 HER2 positive metastatic breast 63 plus prednisone 63 Imprime PGG 63 EGFR expressing mCRC 63 relapsed refractory multiple myeloma 63 adecatumumab 63 IMC A# 63 Herceptin trastuzumab 63 AeroLEF TM 63 Oxaliplatin 63 Advancing Drugs 63 Recombinant Human 63 QVA# 63 R bortezomib 63 sodium Injection

Back to home page